“With our next generation sleek design and consistent accuracy, eBwell is the Blood Glucose Monitoring System you can rely on,” said Dr. Ken-Shwo Dai, Ph.D., CEO, Visgeneer Group. “On top of our range of glucose monitoring systems, we will soon be launching blood monitors measuring ketone levels later this year.”

For more information on our eBwell Blood Glucose Monitoring System, please click here.

About Visgeneer Group

Based in Hsinchu, Taiwan, Visgeneer Group is a global innovator for health solutions encompassing blood diagnostics, EU Patent skincare, zeaxanthin and cancer gene testing. Since our inception in 2005, we have produced award-winning products and industry firsts and continue to work relentlessly to empower individuals, regardless of health conditions they may have, to live life to their fullest under our vision "Envisioning the world anew. Engineering for Generations to come." Visgeneer is listed in Taiwan with stock ticker 4197. For more information on Visgeneer Group, please visit www.visgeneer.com/en.